• 
  L. Thorel, J. Divoux, J. Lequesne, G. Babin, P. M. Morice, et al.. The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers. BMC Cancer, 2024, BMC Cancer, 24 (1), pp.701. ⟨10.1186/s12885-024-12429-w⟩. ⟨hal-04680940⟩
• 
  A. Wambecke, M. Ahmad, P. M. Morice, B. Lambert, L. B. Weiswald, et al.. The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.. Molecular Oncology, 2021, Mol Oncol, 15 (12), p. 3659-3678. ⟨10.1002/1878-0261.13045⟩. ⟨hal-04442817⟩
• 
  Madjid Djouina, Christophe Waxin, Segolene Caboche, Karine Lecointe, A. Steimle, et al.. Low dose dietary contamination with deoxynivalenol mycotoxin exacerbates enteritis and colorectal cancer in mice.. Science of the Total Environment, 2023, Sci Total Environ, 900, pp.165722. ⟨10.1016/j.scitotenv.2023.165722⟩. ⟨hal-04443870⟩
• 
  Florent Salvador, Laure Deramoudt, Frédéric Leprêtre, Martin Figeac, Thomas Guerrier, et al.. A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion.. Frontiers in Immunology, 2022, Frontiers in Immunology, 13, pp.755900. ⟨10.3389/fimmu.2022.755900⟩. ⟨hal-04442749⟩
• 
  Alexia Mopin, Frédéric Leprêtre, Shéhérazade Sebda, Celine Villenet, Meriem Ben Khoud, et al.. Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.. PLoS ONE, 2022, PLoS One, 17 (4), pp.e0267508. ⟨10.1371/journal.pone.0267508⟩. ⟨hal-04442721⟩

13

16